Dyne Therapeutics, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q3 2019 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Dyne Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2019 to Q4 2024.
  • Dyne Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending December 31, 2024 was $10.5M, a 82.8% increase year-over-year.
  • Dyne Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2024 was $45.9M, a 130% increase year-over-year.
  • Dyne Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $45.9M, a 130% increase from 2023.
  • Dyne Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $20M, a 31.6% increase from 2022.
  • Dyne Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $15.2M, a 13.5% decline from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 $45.9M $10.5M +$4.75M +82.8% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-27
Q3 2024 $41.1M $8.75M +$3.87M +79.4% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $37.2M $6.74M +$1.99M +41.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $35.3M $19.9M +$15.3M +331% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $20M $5.73M +$1.9M +49.6% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-27
Q3 2023 $18.1M $4.88M +$1.05M +27.4% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $17M $4.75M +$1.72M +56.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 $15.3M $4.62M +$129K +2.87% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $15.2M $3.83M -$2.18M -36.3% Oct 1, 2022 Dec 31, 2022 10-K 2025-02-27
Q3 2022 $17.4M $3.83M +$189K +5.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-30
Q2 2022 $17.2M $3.03M -$1.21M -28.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $18.4M $4.49M +$836K +22.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $17.5M $6.01M +$1.8M +42.7% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-02
Q3 2021 $15.7M $3.64M +$1.4M +62.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $14.3M $4.24M +$4.16M +5552% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $10.2M $3.65M +$3.59M +5433% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-02
Q4 2020 $6.59M $4.22M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-10
Q3 2020 $2.24M +$2.23M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $75K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $66K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q3 2019 $7K* Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.